Mounjaro injection, containing the active ingredient tirzepatide, is an innovative treatment originally developed for type 2 diabetes and increasingly used for weight loss. It works by activating both GLP-1 and GIP receptors, which help regulate blood sugar, control appetite, and slow digestion. Administered once weekly as a subcutaneous injection, Mounjaro has shown impressive results in clinical studies, with many patients experiencing significant weight reduction. While highly effective, it may cause side effects such as nausea, diarrhea, or reduced appetite. Mounjaro injection should always be used under medical supervision to ensure safety and suitability for individual health needs.

yourpharmacy.uk